Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.74 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.74 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.621.1 (Mu)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.621.1 (Mu)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.621.1 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621.1 (Mu)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BQ.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.16.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.16.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used